Jearanaiwitayakul T, Sunintaboon P, Kittiayuwat A, Limthongkul J, et al. Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development. Vaccine 2024 May 6:S0264-410X(24)00519-X. doi: 10.1016/j.vaccine.2024.
PMID: 38714446